MaxCyte, Inc. (MXCT)

MaxCyte Revenue

MaxCyte had revenue of $8.16M in the quarter ending September 30, 2024, with 2.00% growth. This brings the company's revenue in the last twelve months to $45.60M, up 19.85% year-over-year. In the year 2023, MaxCyte had annual revenue of $41.29M, down -6.72%.

• Revenue (ttm): $45.60M
• Revenue Growth: +19.85%
• P/S Ratio: n/a
• Revenue / Employee: $318,874
• Employees: 143
• Market Cap: 438.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%
Dec 31, 2019	21.62M	4.95M	29.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.